Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Di

Showing results (241-250 of 293) with videos related to

Pageof 30
Sort By:
Molecular Pharmaceutics|October 9, 2023
The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic ClearanceChristopher E Keefer, George Chang, Li Di, et al.
Academic Radiology|February 27, 2025
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCCYing-Wen Hou, Tian-Qi Zhang, Li-Di Ma, et al.
Journal of Medicinal Chemistry|February 9, 2012
2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonistsDahui Zhou, Jonathan L Gross, Adedayo B Adedoyin, et al.
CNS Neuroscience & Therapeutics|October 14, 2025
Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia GravisYaye Wang, Wenjia Zhu, Qing Liu, et al.
CNS Neuroscience & Therapeutics|June 1, 2026
Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and SafetyZhangyan Geng, Yuting Jiang, Nairong Xie, et al.
Molecular Pharmaceutics|April 15, 2014
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug dispositionDennis Smith, Per Artursson, Alex Avdeef, et al.
Pharmacology Research & Perspectives|October 19, 2019
Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicityGrant Generaux, Vinal V Lakhani, Yuching Yang, et al.
The Journal of Investigative Dermatology|June 11, 2021
Molecular Genetic Dissection of Inflammatory Linear Verrucous Epidermal Naevus Leads to Successful Targeted TherapyMelissa Riachi, Satyamaanasa Polubothu, Paulina Stadnik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Neuromuscular Disorders : NMD|May 7, 2024
A rare complex structural variant of novel intragenic inversion combined with reciprocal translocation t(X;1)(p21.2;p13.3) in Duchenne muscular dystrophyYaye Wang, Xinmei Wen, Xin-Ming Shen, et al.
Pageof 30

Showing results (241-250 of 293) with videos related to

Sort By:
Pageof 30
Molecular Pharmaceutics|October 9, 2023
The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic ClearanceChristopher E Keefer, George Chang, Li Di, et al.
Academic Radiology|February 27, 2025
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCCYing-Wen Hou, Tian-Qi Zhang, Li-Di Ma, et al.
Journal of Medicinal Chemistry|February 9, 2012
2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonistsDahui Zhou, Jonathan L Gross, Adedayo B Adedoyin, et al.
CNS Neuroscience & Therapeutics|October 14, 2025
Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia GravisYaye Wang, Wenjia Zhu, Qing Liu, et al.
CNS Neuroscience & Therapeutics|June 1, 2026
Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and SafetyZhangyan Geng, Yuting Jiang, Nairong Xie, et al.
Molecular Pharmaceutics|April 15, 2014
Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug dispositionDennis Smith, Per Artursson, Alex Avdeef, et al.
Pharmacology Research & Perspectives|October 19, 2019
Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicityGrant Generaux, Vinal V Lakhani, Yuching Yang, et al.
The Journal of Investigative Dermatology|June 11, 2021
Molecular Genetic Dissection of Inflammatory Linear Verrucous Epidermal Naevus Leads to Successful Targeted TherapyMelissa Riachi, Satyamaanasa Polubothu, Paulina Stadnik, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Neuromuscular Disorders : NMD|May 7, 2024
A rare complex structural variant of novel intragenic inversion combined with reciprocal translocation t(X;1)(p21.2;p13.3) in Duchenne muscular dystrophyYaye Wang, Xinmei Wen, Xin-Ming Shen, et al.
Pageof 30